CEO: Michael Gilman

Advent Contact: Raj Parekh

First-in-class small molecule modulators of RNA

Arrakis is building a proprietary platform to enable the rational, structure-based design of orally acting small molecules that bind RNA, and so directly modulate RNA function.

Advent founded Arrakis in 2014.

 

Back